Aditxt (ADTX) Receivables - Other (2023)
Aditxt (ADTX) recorded quarterly Receivables - Other of $5.4 million in Q4 2023.
Aditxt (ADTX) Receivables - Other (2023) Analysis & Trends
Aditxt's Receivables - Other history runs 1 years deep, the most recent figure standing at $5.4 million for Q4 2023.
- In Q4 2023, Receivables - Other changed N/A year-over-year to $5.4 million; the TTM figure through Dec 2023 stood at $5.4 million (changed N/A YoY), while the FY2023 annual figure was $5.4 million, changed N/A from the prior year.
- Receivables - Other was $5.4 million for Q4 2023 at Aditxt.
- In the past five years, Receivables - Other ranged from a high of $5.4 million in Q4 2023 to a low of $5.4 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 5.44 Mn |
| Dec 31, 2023 | 5.44 Mn |